IL17A and myocardial ischemia: In a murine model of isoproterenol-induced myocardial ischemia, it has been recently showed that exogenous HMGB1 treatment aggravated myocardial injury and increased both the CD4/CD8 ratio and the expression level of interleukin-17 (IL-17) compared to untreated infarcted mice.